Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options-Reference-Cited by-同舟云学术

Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options

Published:2013-04 Issue:4 Volume:58 Page:655-662
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Suzuki Yoshiyuki,Ikeda Kenji,Suzuki Fumitaka,Toyota Joji,Karino Yoshiyasu,Chayama Kazuaki,Kawakami Yoshiiku,Ishikawa Hiroki,Watanabe Hideaki,Hu Wenhua,Eley Timothy,McPhee Fiona,Hughes Eric,Kumada Hiromitsu

Funder

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Hepatology

Reference26 articles.

1. Boceprevir for untreated chronic HCV genotype 1 infection;Poordad;N Engl J Med,2011

2. Telaprevir for previously untreated chronic hepatitis C virus infection;Jacobson;N Engl J Med,2011

3. Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy;Poynard;Gastroenterology,2009

4. Telaprevir for retreatment of HCV infection;Zeuzem;N Engl J Med,2011

5. Efficacy of boceprevir in prior null responders to peginterferon/ribavirin: the PROVIDE study [abstract];Vierling;Hepatology,2011

Cited by 216 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural and Synthetic Aspects of Small Ring Oxa- and Aza-Heterocyclic Ring Systems as Antiviral Activities;Viruses;2023-08-28

2. Real-World Therapeutic Outcomes of Direct-Acting Antiviral Regimens and Formidable Challenges;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01

3. Curing Hepatitis C with Direct‐Acting Antiviral Therapy;New Drug Development for Known and Emerging Viruses;2021-12-03

4. Follow-up after Direct-acting Antiviral Treatment for Chronic Hepatitis C Virus Infection: Most Patients Are Followed Appropriately;Internal Medicine;2021-10-01

5. Asunaprevir, a Potent Hepatitis C Virus Protease Inhibitor, Blocks SARS-CoV-2 Propagation;Molecules and Cells;2021-09-30